Michael Silber, Author at In The States

About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2747 blog entries.

Washington

The telemedicine rules workshop scheduled for June 4 was canceled. For more information about when it will be rescheduled, contact Amelia Boyd, Program Manager, at amelia.boyd@wmc.wa.gov.

Also in Washington, the Health Care Authority (HCA) issued a primary care stakeholder survey aimed at gathering provider and other stakeholder input on proposed provider accountabilities under the WA Multi-payer Primary Care Transformation Model. Feedback from this survey will be combined with payer input to build out an overall framework of accountabilities for both providers and payers under the Model.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Michael Silber2021-06-04T12:55:09-04:00June 4, 2021|Washington|

California

AB 1430, legislation requiring pharmacies to dispense Schedule II prescription drugs in lockable vials, was held on the Assembly Appropriations Suspense File and will not advance.

Also in California, the following bills failed the policy/legislative deadline and have become two-year bills. They may not be acted upon until January 2022.

AB 458, legislation creating the Affordable Prescription Drug Importation Program in the California Health and Human Services Agency (CHHSA), under which the state would be a licensed wholesaler that imports prescription drugs for the exclusive purpose of dispensing those drugs to program participants upon federal approval for the importation program.
AB 933, legislation requiring an enrollee’s or insured’s defined cost-sharing for each prescription drug to be calculated at the point-of-sale based on a price that is reduced by an amount equal to 90% of all rebates received, or to be received, in connection with the dispensing or administration of the drug. It would also prohibit a health care service plan, health insurer, or a plan’s or insurer’s agents from publishing or otherwise revealing information regarding the actual amount of rebates the health care service plan or health insurer receives on a product-specific, manufacturer-specific, or pharmacy-specific basis.

Also in California, the Office of Administrative Law has approved the following proposals. The amended and new regulations are effective July 1, 2021.

To amend sections 1711 and 1713, and add section 1715.1, in Article 2 of Division 17 of Title 16 of the California Code of Regulations, regarding Automated Drug Delivery Systems.
To amend section 1707 in Article 2 of Division 17 of Title 16 of the California Code of Regulations, regarding Waiver Requirements for Off-site Storage of Records.

Lastly in California, the Department of Health Care Services posted the User Administration Console (UAC) Registration Troubleshooting bulletin on the Medi-Cal Rx web portal. Additionally, DHSC issued the Medi-Cal Rx User Administration Console (UAC) Application Role bulletin to prepare pharmacies and prescribers for the upcoming Medi-Cal Rx transition by providing information on the currently available applications and their functionalities within the Medi-Cal Rx Secured Provider Portal.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Michael Silber2021-05-28T09:57:07-04:00May 28, 2021|California|

Florida

The Florida Board of Pharmacy issued a proposed rule that would amend regulations under FAC 64B16-31 to update references to the incorporated application forms for pharmacy interns, consultant pharmacists, nuclear pharmacists, and pharmacy technicians. Comments and hearing requests are due June 14, 2021.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

Michael Silber2021-05-28T09:53:58-04:00May 28, 2021|Florida|

Georgia

The Georgia Board of Pharmacy issued a final rule to amend regulations under GAC 480-10 to require a Class A balance with weights or electronic balance only if compounding on-site using components that must be weighed. The rule became effective May 10.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

Michael Silber2021-05-28T09:53:14-04:00May 28, 2021|Georgia|

Iowa

The next meeting of the Iowa Board of Pharmacy’s IMP3 Committee meeting is scheduled for June 2, 2021. The information and agenda have been posted.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Michael Silber2021-05-28T09:52:09-04:00May 28, 2021|Iowa|

Oklahoma

In The Oklahoma Register Vol. 38 No. 17, the Oklahoma Health Care Authority published an emergency rule amending regulations under OAC 317:30-5 to revise provisions regarding diabetes self-management education and support providers to update requirements for Medicaid payment of providers and requirements that such providers be certified. The rule also allows registered dietitians, registered nurses, and pharmacists to render services and be reimbursed when meeting specific licensure, training, and experience requirements. The rule became effective April 14 and expires September 14, 2022.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Michael Silber2021-05-28T09:51:13-04:00May 28, 2021|Oklahoma|

Texas

On May 26, Gov. Abbott signed HB1763 into law which becomes effective September 1, 2021. NACDS applauds Gov. Abbott, Sen. Lois Kolkhorst (R), Rep. Tom Oliverson (R), Sen. Bryan Hughes (R), and Rep. Eddie Lucio III (D) for passing this important legislation and look forward to continued collaboration on these efforts that maintain patient access and creates long-term viable reimbursement models in the commercial market. HB1763 is crucial for the continued viability of retail community pharmacies in Texas by creating PBM reform that prohibits harmful claw backs, requires that all pharmacies be fairly and properly reimbursed, and provides patients with equal access to all network pharmacies by allowing patients to receive care from the pharmacy of their choice. In a letter of support, NACDS urged Gov. Abbott to sign HB1763 to maintain patient access and help ensure that local Texas pharmacies are properly reimbursed for the prescription medications they provide and associated pharmacy services.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Michael Silber2021-05-28T09:50:10-04:00May 28, 2021|Texas|

Virginia

The Board of Pharmacy has posted the agenda for the June 4 meeting. The BOP will be reviewing legislation passed by the General Assembly in the 2021 session including HB 2079 (initiation of treatment, dispensing of supplies and devices; HIV treatment; test & treat for CLIA-waived tests including flu and strep; tobacco cessation prescribing). A stakeholders’ workgroup will be convened to make recommendations on CLIA test and treat to the Joint Commission on Health Care due November 1, 2021. Additionally, there will be another workgroup tasked with making recommendations on expansion pharmacy technicians’ duties as a result of the passage of HB 1304 of 2020 with a report also due November. 1. Further detail is in the agenda packet. NACDS and VACDS expect to participate in both stakeholder workgroups.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Michael Silber2021-05-28T09:49:16-04:00May 28, 2021|Virginia|

Alabama

The Board of Pharmacy published an emergency rule to adopt regulations under AAC 680-X-2 to establish standards for off-site COVID vaccine order entry processing. The rule is effective April 7 and expires October 2, 2021. Please contact Wendy Passmore; Board of Pharmacy; 205-981-4764; wpassmore@albop.com for more information.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

Michael Silber2021-05-21T10:13:47-04:00May 21, 2021|Alabama|